Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Schabert
PMS15 Costs of Tumor Necrosis Factor Blockers Per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population
Journal of Managed Care Pharmacy
Cost of Tumor Necrosis Factor Blockers Per Patient With Rheumatoid Arthritis in a Multistate Medicaid Population
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Prevalence and Incidence of Acute Urogenital Conditions in a Us Commercially-Insured Population
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Characteristics, Health Care Utilization and Costs Among Men With Primary or Secondary Hypogonadism in a US Commercially Insured Population
Journal of Sexual Medicine
Gynecology
Reproductive Medicine
Urology
Obstetrics
269 Comorbidity Clusters in Hidradenitis Suppurativa in a Large Commercially Insured Population in the US
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population
Digestive Diseases and Sciences
Physiology
Gastroenterology
Characterization of Insufficient Responders to Anti-Tumor Necrosis Factor Therapies in Patients With Moderate to Severe Psoriasis: Real-World Data From the US Corrona Psoriasis Registry
Journal of Dermatological Treatment
Dermatology
Impact of Medication Therapy Management (MTM) Services on Health Care Costs in Polypharmacy Patients: Evidence From Retrospective Claims Analysis of Commercially Insured Us Population
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Healthcare Resource Utilization and Costs in Amyloid Light-Chain Amyloidosis: A Real-World Study Using US Claims Data
Journal of Comparative Effectiveness Research
Health Policy
